HR c.331_332delinsAC ;(p.C111T)

Variant ID: 8-21986352-CA-GT

NM_005144.4(HR):c.331_332delinsAC;(p.C111T)

This variant was identified in 3 publications

View GRCh38 version.




Publications:


Impact of Polymorphic Variations of Gemcitabine Metabolism, DNA Damage Repair, and Drug-Resistance Genes on the Effect of High-Dose Chemotherapy for Relapsed or Refractory Lymphoid Malignancies.

Biology Of Blood And Marrow Transplantation : Journal Of The American Society For Blood And Marrow Transplantation
Shinozuka, Keiji K; Tang, Hongwei H; Jones, Roy B RB; Li, Donghui D; Nieto, Yago Y
Publication Date: 2016-05

Variant appearance in text: HR: C111T
PubMed Link: 26743341
Variant Present in the following documents:
  • Main text
View BVdb publication page



Gemcitabine metabolic and transporter gene polymorphisms are associated with drug toxicity and efficacy in patients with locally advanced pancreatic cancer.

Cancer
Tanaka, Motofumi M; Javle, Milind M; Dong, Xiaoqun X; Eng, Cathy C; Abbruzzese, James L JL; Li, Donghui D
Publication Date: 2010-11-15

Variant appearance in text: HR: C111T
PubMed Link: 20665488
Variant Present in the following documents:
  • Main text
View BVdb publication page



Single nucleotide polymorphisms of gemcitabine metabolic genes and pancreatic cancer survival and drug toxicity.

Clinical Cancer Research : An Official Journal Of The American Association For Cancer Research
Okazaki, Taro T; Javle, Milind M; Tanaka, Motofumi M; Abbruzzese, James L JL; Li, Donghui D
Publication Date: 2010-01-01

Variant appearance in text: HR: C111T
PubMed Link: 20028759
Variant Present in the following documents:
  • Main text
View BVdb publication page